TTK Healthcare Limited has successfully completed its postal ballot process for the appointment of a new Independent Director, with shareholders demonstrating strong support for the corporate governance initiative. The company announced the voting results on January 27, 2026, following the completion of the e-voting process.

Appointment Details and Resolution Outcome

The special resolution for appointing Mr V Sundaresan (DIN: 11435475) as an Independent Director was passed with overwhelming shareholder approval. The appointment is effective from December 22, 2025, for a term of 5 years.

E-Voting Process and Timeline

The postal ballot process was conducted entirely through electronic means, in compliance with MCA circulars and SEBI regulations. The e-voting commenced on Friday, December 26, 2025, at 9.00 A.M. (IST) and concluded on Saturday, January 24, 2026, at 5.00 P.M. (IST).

Key process highlights include:

• Record Date: December 19, 2025
• Notice Dispatch: December 24, 2025 (via email to registered shareholders)
• Advertisement Publication: December 25, 2025 in Makkal Kural (Tamil) and Business Standard (English)
• Vote Unblocking: January 26, 2026, at 11.05 A.M. (IST)

Category-wise Voting Analysis

The voting participation varied significantly across different shareholder categories:

Scrutinizer Appointment and Report

The Board of Directors appointed M/s A K Jain & Associates, Practising Company Secretaries, represented by partners Mr Balu Sridhar and Mr Anil Kumar Jain, as scrutinizers for the postal ballot process. The scrutinizer submitted their report on January 27, 2026, confirming the fair and transparent conduct of the voting process.

The scrutinizer's report confirmed that no invalid votes were recorded across any shareholder category, and all procedural requirements under the Companies Act 2013 and SEBI regulations were duly complied with.

Regulatory Compliance and Documentation

TTK Healthcare ensured full compliance with regulatory requirements, including Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The voting results have been made available on the company's website and will be uploaded on CDSL's e-voting platform. The company has also filed the necessary documentation with BSE Limited and National Stock Exchange of India Limited, maintaining transparency in corporate governance practices.

TTK Healthcare has reported its third quarter financial performance, showing a considerable decline in net profitability compared to the same period last year. The healthcare company's bottom line faced significant pressure during the quarter under review.

Financial Performance Overview

The company's financial results for the third quarter reveal a substantial drop in net profit margins. The year-on-year comparison indicates challenging operating conditions that impacted the company's profitability during this period.

Key Financial Highlights

The third quarter results demonstrate the impact of various factors on TTK Healthcare's financial performance. The company recorded a net profit of ₹10.50 crores during the quarter, marking a significant decrease from the ₹16.70 crores achieved in the corresponding quarter of the previous fiscal year.

This decline of ₹6.20 crores in absolute terms represents a percentage decrease of 37.13% year-on-year. The substantial reduction in net profit indicates that the company faced operational challenges or market conditions that affected its profitability during the reporting period.

Performance Analysis

The year-on-year comparison reveals the extent of the profit decline experienced by TTK Healthcare. The company's ability to maintain its previous year's profitability levels was significantly impacted during the third quarter, as evidenced by the sharp drop in net profit figures.

The financial performance reflects the current business environment and operational dynamics affecting the healthcare sector company during this reporting period.